Biotherapeutics: position papers (part I) Published on: 24 July 2014 Downloads » Questions & Answers on Biotherapeutic & Biosimilar Medicines (EN) » Questions & Answers on Biotherapeutic & Biosimilar Medicines (PT) » Questions & Answers on Biotherapeutic & Biosimilar Medicines (JP) » Policy Statement on Non-comparable Biotherapeutic Products (EN) » Policy Statement on Non-comparable Biotherapeutic Products (SP) » Policy Statement on Non-comparable Biotherapeutic Products (BN) » Policy Statement on Non-comparable Biotherapeutic Products (MY) » Policy Statement on Non-comparable Biotherapeutic Products (KM) » Policy Statement on Non-comparable Biotherapeutic Products (SI) » Policy Statement on Non-comparable Biotherapeutic Products (TA) » Policy Statement on Non-comparable Biotherapeutic Products (TH) » Policy Statement on Non-comparable Biotherapeutic Products (VI) » Position Paper on Pharmacovigilance Principles for Biotherapeutic Medicines (EN) Resources Position Papers Biotherapeutics: position papers (part II) Infographics Good pharmacovigilance principles to ensure biotherapeutics safety Publications Biotherapeutic medicines: Grasping the new generation of treatments Videos IFPMA: Biotherapeutic medicines explained Publications Pharmacovigilance – Good pharmacovigilance principles and considerations for biotherapeutic medicines Publications Similar biotherapeutic products: Scientific & regulatory considerations Related Topics Biotherapeutic medicines Biosimilars Tags BiosimilarsIFPMANon-comparable Biotherapeutic ProductsPharmacovigilancePolicy Statement